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Placebo and nocebo effects are intriguing phenomena in pain perception with important implications for clinical research and
practice because they can alleviate or increase pain. According to current theoretical accounts, these effects can be shaped by verbal
suggestions, social observational learning, and classical conditioning and are necessarily mediated by explicit expectation. In this
review, we focus on the contribution of conditioning in the induction of placebo hypoalgesia and nocebo hyperalgesia and present
accumulating evidence that conditioning independent from explicit expectation can cause these effects. Especially studies using
subliminal stimulus presentation and implicit conditioning (i.e., without contingency awareness) that bypass the development of
explicit expectation suggest that conditioning without explicit expectation can lead to placebo and nocebo effects in pain
perception. Because only few studies have investigated clinical samples, the picture seems less clear when it comes to patient
populations with chronic pain. However, conditioning appears to be a promising means to optimize treatment. In order to get
a better insight into the mechanisms of placebo and nocebo effects in pain and the possible benefits of conditioning compared to
explicit expectation, future studies should carefully distinguish both methods of induction.
1. Introduction
Placebo and nocebo effects are prevalent topics in current
research, especially in the domain of pain, where they can be
investigated comparatively easily and serve as a model for
other systems (e.g., immune, motor, and respiratory systems
[1]). While placebo hypoalgesia refers to decreased pain
sensitivity due to an inert treatment (e.g., sham procedure
and inert substance), its counterpart nocebo hyperalgesia is
defined as increased pain sensitivity attributable to an inert
treatment [2]. Due to their capacity to improve or worsen
symptoms and well-being, placebo and nocebo effects are
highly relevant not only in research but also in clinical
practice. ,ey contribute to most therapeutic effects [3],
occur regularly in doctor-patient interactions [4], and are
assumed to play a role in the development and maintenance
of chronic pain and other diseases [5, 6]. Placebo and nocebo
effects also significantly influence the outcome of ran-
domized placebo-controlled clinical trials, for example,
leading to an underestimation of clinical effects of novel
drugs [7–9]. Although this clinical relevance and research on
placebo and nocebo effects have prospered during the past
decade, many issues remain unresolved or poorly un-
derstood. One of these issues that deserve our attention
concerns the causing mechanisms of placebo and nocebo
effects and the significance of conditioning in this realm.
Only if we understand how these effects emerge, we can
systematically take advantage of placebo and avoid nocebo
effects, especially in the clinical context.
After giving a brief overview over current evidence and
models on the development of placebo hypoalgesia and
nocebo hyperalgesia including conditioning and expectation
approaches, we will turn to studies that stress the signifi-
cance of conditioning and demonstrate that conditioning
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effects might have been misunderstood and/or under-
estimated. We will highlight the need to better understand
conditioned placebo and nocebo effects and propose ex-
perimental designs that allow a conclusive investigation of
the specific mechanisms at work.
2. Development of Placebo and Nocebo Effects
Placebo and nocebo effects can be induced by different
means. Empirical evidence shows that verbal suggestion [10],
classical conditioning [11–13], and observational learning
[14, 15] can lead to placebo hypoalgesia and nocebo
hyperalgesia. Verbal suggestions in terms of written or
spoken statements on the alleged effect of the placebo or
nocebo are thought to induce an explicit expectation that
directly mediates the effect [16, 17]. In contrast, direct ex-
perience of a pain-increasing or -relieving effect is essential
in conditioning of placebo hypoalgesia and nocebo hyper-
algesia [18]. Here, a placebo/nocebo serves as conditioned
stimulus and is repeatedly coupled to a pain stimulus
(unconditioned stimulus), in which the intensity is reduced
or increased without the person’s knowledge compared to
before placebo/nocebo administration or to a simultaneous
stimulation without placebo/nocebo. Subsequently, the
conditioned effect is tested by retracting the surreptitious
change in stimulation intensity while still administering the
placebo/nocebo. Observational learning of placebo and
nocebo effects has been investigated only recently. It is
usually carried out by showing videos of or live models who
are demonstrating reduced or increased pain sensations
upon administration of a placebo/nocebo [15, 19–21]. It is
assumed that the observation serves as an unconditioned
stimulus [22].
Typically, conditioning and verbal suggestions are
both implemented in experimental studies to increase
placebo/nocebo effects in pain [23–26]. Accordingly, meta-
analyses come to the conclusion that the combination of
conditioning and verbal suggestion leads to larger effects
than verbal suggestion alone [27, 28]. When inducing pla-
cebo hypoalgesia or nocebo hyperalgesia by verbal sugges-
tions alone, results are inconsistent, sometimes resulting
only in weak [24] or even no effects [25, 29, 30] and at other
times leading to robust pain reduction [10, 31] or increase
[10, 32]. Some studies indicate that learning is less important
in nocebo hyperalgesia compared to placebo hypoalgesia,
but direct comparisons are rare [24, 33]. Interestingly, while
placebo effects induced by expectation can be antagonized
by the opioid antagonist naloxone, conditioned placebo
effects can be antagonized by naloxone when the pharma-
cological conditioning had been performed with an opioid
and by cannabinoid receptor antagonists when it had been
performed with ketorolac, a nonsteroidal anti-inflammatory
drug [34, 35]. ,ese findings highlight that placebo and
nocebo effects in pain differ depending on whether they were
induced by verbal suggestion or conditioning.
In a series of three studies, Benedetti et al. [10] showed
that (a) placebo and nocebo effects in hormone secretion
(growth hormone and cortisol) were affected by pharma-
cological conditioning, but not by verbal suggestions,
(b) placebo and nocebo effects in pain were induced by
pharmacological conditioning and by verbal suggestions, but
pharmacologically conditioned placebo hypoalgesia was
overridden by opposing verbal suggestions, and (c) motor
performance in Parkinsonian patients depended on verbal
suggestion after repeated deactivation of implanted stimu-
lating electrodes. Based on these observations, the authors
developed an influential model stating that conditioning can
directly lead to placebo and nocebo effects in unconscious
processes (e.g., hormone secretion) and that expectation can
lead to placebo and nocebo effects in conscious processes
(e.g., pain and motor performance) and that effects of
conditioning on conscious processes are necessarily medi-
ated by explicit expectation. Furthermore, it is assumed that
expectation cannot directly affect unconscious processes
[10]. Although these conclusions fit to the results of the
presented studies, we assert that the model underestimates
conditioned effects, as outlined below.
Previous research on the mechanisms of placebo and
nocebo effects might be biased due to a number of reasons:
(1) studies that investigate the effects of conditioning without
verbal suggestion are scarce [30, 36, 37]. In order to estimate
the contribution and investigate the mechanisms of con-
ditioning to a given effect, it is likely not as simple as to
subtract the effect size from a verbal suggestion group from
that of a verbal suggestion plus conditioning group. It
could well be that conditioning and verbal suggestion do
not interact in an additive manner, although this seems to
be assumed in most studies. (2) When investigating the
effects of a conditioning procedure without verbal sugges-
tions, oftentimes a medically connoted placebo or nocebo
(e.g., ointment, pill, and sham acupuncture) is used
[13, 29, 38, 39]. However, these placebos and nocebos most
probably induce expectations from the outset independent
of the experimental manipulation. Participants might have
been preconditioned by previous experiences with similar
medical devices and procedures. As a consequence, un-
intended additional expectations will develop that compli-
cate disentangling expectation- and conditioning-induced
effects. Evidence supporting this assumption comes from
a study by Montgomery and Kirsch [39], in which a small
placebo effect emerged after applying an inert tincture
without giving a verbal suggestion and before conditioning.
(3) Another pitfall of many studies testing conditioned ef-
fects is the implementation of the conditioning procedure
itself. Due to credibility, a medically connoted placebo or
nocebo, like an ointment, will only be applied once in the
beginning of the study, for example, on the right arm,
and then tested against a spot without ointment, for ex-
ample, on the left arm [12, 13, 39–42]. In other cases, the
placebo/nocebo is applied only very few times [11, 43].
Proper conditioning, however, relies on repeated pairings of
the conditioned stimulus (i.e., the placebo or nocebo) and
the unconditioned stimulus (i.e., reduced or increased pain)
(e.g., [44]). It is known from the conditioning literature that
conditioned effects are stronger when more pairings of CS
and US are applied [45]. By applying a placebo/nocebo only
once, it cannot be ensured that the pairing is processed as
intended. To summarize, most previous studies do not allow
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disentangling of placebo/nocebo effects induced by condi-
tioning and/or explicit expectations or do not use adequate
conditioning procedures to test for conditioned effects so
that conditioned placebo and nocebo effects can hardly be
evaluated.
3. Mediation by Expectation Hypothesis
An important aspect of the above-cited model [10] concerns
the necessary mediation of conditioning effects in pain via
explicit expectation. Colloca and Miller [22] developed
a learning perspective on placebo responses by applying
Peirce’s theory of signs and refining Benedetti’s model
[10]. In addition to Benedetti’s model, they state that signs
in the form of indices (i.e., conditioned stimuli), symbols
(i.e., communication), and icons (i.e., observations) are
detected and processed, resulting in the formation of ex-
pectations, which thereby contribute to placebo and nocebo
responses. In line with Benedetti’s model, bodily functions
that are consciously accessible, as pain relief, are mediated by
expectation, but “an event that cannot be experienced and
perceived by human cognition (e.g., growth factor secretion)
appears not to be influenced by self-cognition” (p. 1865).
Although the authors endorse the possibility of conditioning
without awareness, and accordingly unconscious expecta-
tions, they argue that it is circumstantial in creatures with
higher phylogenetic level. In the following, we will show that
conditioned placebo hypoalgesia and nocebo hyperalgesia
are not necessarily mediated by explicit expectations, em-
phasizing the assumption that the conditioned effect can
exist independent of explicit expectation.
Many studies report correlations between pain and
expected pain ratings [17, 39, 46, 47], sometimes on a trial-
by-trial basis [26], after conducting a conditioning pro-
cedure. Using a mediation analysis, it has been shown that
conditioning is highly related to expectancy and expectancy
predicts the placebo effect, while the direct effect of con-
ditioning on the placebo effect is no longer significant [38].
,is result suggests that conditioning is mediated by ex-
pectation. However, the robustness of this outcome seems
somewhat uncertain, as a bias-corrected bootstrap approach
was not significant. A study of Montgomery and Kirsch [39]
can serve as another example for mediation by expectation.
,ey compared a conditioned group (uninformed pairing)
to a group with informed pairing (i.e., participants un-
derwent a conditioning procedure but were informed about
the intensity reduction on placebo trials), and a control
group that was not conditioned. ,e strongest placebo effect
appeared in the uninformed pairing group, but when in-
cluding expectancy as a covariate, group differences dis-
appeared and expectancy was significantly related to placebo
effects. Furthermore, some studies report that conditioned
effects can be blocked by opposite verbal suggestions [10, 39].
However, this is not always the case, as there are studies
showing conditioned effects despite opposite verbal sug-
gestions [11, 12] or expectancy [48]. Also, conditioned effects
have been shown to be mediated by expectancy only partially
[49], and expectation ratings do not necessarily predict
conditioned effects [37, 50] or correspond to pain ratings
[29]. In a study of De Pascalis et al. [41], two placebo creams
were administered with supposedly “strong” and “weaker”
dosage. Subsequently, only after application of the “strong
placebo,” the intensity of electric pain stimuli was surrep-
titiously reduced. Although expected pain level varied
according to the manipulation (i.e., strong placebo led to
higher expectation of pain relief compared to weak placebo),
pain ratings did no differ after strong and weak placebo,
highlighting the dissonance between expectations and
measured placebo hypoalgesia.
Studies on open-label placebo administration give an-
other important insight into the mediating role of expec-
tation in placebo hypoalgesia. Typically, open-label placebo
studies try to boost expectation of a positive effect despite
openly administering an inert substance [51, 52]. However,
a highly intriguing study in healthy participants showed that
conditioned placebo hypoalgesia persisted after revealing the
inert nature of a placebo intervention (cream) independent
of the participants’ expectation. Other than in the previously
mentioned open-label placebo studies, participants in this
study were not encouraged to believe in a positive effect from
the placebo cream. Although participants no longer expected
a hypoalgesic effect, the placebo effect remained [50]. In
a recent systematic review and meta-analysis on open-label
placebo studies, it was hypothesized that the mechanism
driving such effects is classical conditioning [53].
In an editorial, Wager [54] begs interesting questions on
the role of expectation as a mediator of placebo effects. He
argues that, despite the predictive value of expectation for
placebo effects, a causal relationship is not necessarily implied.
Besides a direct influence of expectation on pain experience,
he proposes three alternative explanations for the observed
effects: expectancy could affect reported pain ratings (1) di-
rectly, (2) via a kind of social contract that is initiated after
giving an expectancy rating, and (3) as a consequence of the
third variable that affects both expectancy and pain rating, like
demand characteristics, personality traits, treatment history,
or situational factors. Supporting these ideas, a study of de
Jong et al. [29] can be consulted, in which three different
groups were investigated: the experimental group underwent
a conditioning procedure with additional verbal suggestions,
control group 1 underwent the same conditioning procedure
but was told that stimulus intensities would be halved during
trials, in which the placebo was applied, and that an inert
substance was used, and control group 2 received verbal
suggestions only. Despite similar differential expectations of
the experimental group and control group 2, only the ex-
perimental group showed placebo hypoalgesia. Although no
placebo effect was found in control group 1, pain ratings did
not differ between the experimental group and control group
1, suggesting a relative independence from verbally induced
expectations. Yet, expectation was found to correlate with the
placebo hypoalgesia, however, irrespective of the experi-
mental manipulation. ,e authors speculate that this corre-
lation reflects an interaction between individual traits and
general characteristics of the placebo used, thus possibly
serving as an example for Wager’s third case.
In conclusion, mediation by expectation of conditioned
placebo hypoalgesia and nocebo hyperalgesia can occur but
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in many cases does not. We therefore now turn to studies
that demonstrate the significance of conditioning effects
independent of explicit expectation.
4. Evidence for the Significance of
Classical Conditioning
Evidence of different research areas highlights the signifi-
cance of conditioning of placebo hypoalgesia and nocebo
hyperalgesia that is independent of explicit expectation. It
has been shown that besides humans, animals, such as ro-
dents, can develop conditioned placebo hypoalgesia and
nocebo hyperalgesia [55–57]. Furthermore, a limited
number of studies implemented placebo or nocebo condi-
tioning procedures without additional verbal suggestions
and used meaningless cues as conditioned stimuli (e.g., red
and green lights), instead of medically connoted substan-
ces or procedures, bypassing some of the abovementioned
limitations of previous studies. Results are inconsistent:
while recent studies found placebo hypoalgesia and nocebo
hyperalgesia after conditioning without additional verbal
suggestions that were not predicted by expectancy ratings
[37], or without contingency awareness [58], other studies
reported no placebo hypoalgesia or nocebo hyperalgesia
after conditioning without additional verbal suggestions
[30, 36].
A line of research that strongly supports the existence of
conditioned placebo and nocebo effects in pain that are
independent of explicit expectation uses subliminal cues and
implicit conditioning, that is, conditioning without con-
tingency awareness. Some studies showed that placebo
hypoalgesia and nocebo hyperalgesia that had been condi-
tioned with supraliminally presented cues (i.e., explicit
conditioning) can be activated by subliminally presented
cues [21, 59]. Jensen et al. [60], for instance, conditioned
healthy participants with the display of faces and activated
placebo hypoalgesia and nocebo hyperalgesia by supralim-
inal as well as subliminal face presentation [60].,ese results
were replicated in a functional magnetic resonance imaging
(fMRI) study of the same working group [61].
One attempt to implicitly condition placebo hypoalgesia
by using a tactile cue (direction in which a placebo cream
was applied to the skin) was not successful in inducing
placebo hypoalgesia [43], but a recent study indicated that
contingency awareness is not necessary to induce a nocebo
effect in heat-pain perception [58]. So far, there is only one
study that used a subliminal stimulus presentation also
during the acquisition phase of a conditioning experiment in
order to rule out explicit expectation in conditioning [44].
,e authors assigned healthy participants to one of four
groups, each including an acquisition phase and a test phase
and varying subliminal and supraliminal stimulus pre-
sentations. Overall, F tests indicated that there was no
difference in placebo hypoalgesia and nocebo hyperalgesia
between the different types (i.e., subliminal/supraliminal) of
the acquisition or test phase, strongly suggesting the pres-
ence of implicitly conditioned effects.
In order to gain more insight into the role of conditioned
effects on placebo and nocebo effects in pain, research on
implicit conditioning should be expanded and diversified, as
previous studies mostly did not directly test for contingency
awareness and typically focused on subliminal conditioning,
which has some pitfalls (e.g., intra- and interindividually
varying threshold for subliminal stimulus presentation).
Although accumulating evidence points to an important role
of conditioning of placebo and nocebo effects in pain in-
dependent of explicit expectations, most current theoretical
accounts do not yet incorporate these aspects sufficiently
[10, 22]. One point of criticism regarding prevalent models
concerns the classification of physiological processes into
being either conscious or unconscious. Evidence suggests
that it is conceivable that most, if not all, bodily functions,
including perception and behavior, have “unconscious”
(i.e., outside a person’s awareness; cf., e.g., blindsight and
implicit operant conditioning [62–64]) and “conscious”
(i.e., verbally represented) portions. Pain, especially, is
known as a multidimensional phenomenon that incorpo-
rates sensory, affective, behavioral, and physiological levels
that can all be accessed on aware and unaware levels [63–66].
An exception provides a theoretical framework of Haug
[67], which, however, has not received much attention. He
proposes that placebo/nocebo effects are mediated by so-
called aliefs, which are subdoxastic states, that is, cognitive
states “with consciously inaccessible content which is in-
ferentially isolated from the subject’s large network of beliefs
(and which may directly cause behavior)” (p. 690). Aliefs can
be consciously or unconsciously activated in humans and
nonhumans by the internal or external environment. ,ey
are associative, automatic, arational, affect-laden, and action
generating and might be a better candidate for a common
final path than expectation in Colloca and Miller’s [22]
model because they can explain placebo and nocebo effects
that have been induced by verbal suggestion as well as
(implicit) conditioning.
5. Clinical Context
While the majority of studies on placebo hypoalgesia and
nocebo hyperalgesia examined healthy participants, only few
investigated pain patients and even less focused on clinical
pain [68]. Nonetheless, the available studies give some in-
sights into the mechanisms of placebo and nocebo effects in
a clinical pain context.
Verbal suggestion of pain relief seems to be highly ef-
fective for acute procedural (large effect with Hedges’
g� 1.03) as well as chronic pain (small effect with Hedges’
g� 0.25 [68, 69]) even after open-label placebo adminis-
tration in patients with irritable bowel syndrome (IBS [51])
and chronic low back pain [52]. Furthermore, large placebo
effects (comparable to the effect of the local anesthetic
Lidocain) have been induced by using verbal suggestions and
application of a placebo (lubricant) during the induction of
experimental pain (rectal distention) in patients with IBS
[70, 71]. While explicit expectations accounted for large
amounts of the variance in experimental visceral pain during
placebo and Lidocain administration, it was not predictive
for a cutaneous pain model despite placebo hypoalgesia
being present [70]. In a similar study, expectation did predict
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the placebo and Lidocain effect in the late phase of exper-
imental visceral pain, but not in the early phase [71].
Placebo effects have also been shown in studies that
combined verbal suggestion and conditioning in patients
with IBS [72], knee osteoarthritis [73], atopic dermatitis [40],
musculoskeletal pain [74], and chronic low back pain [69].
Results of a meta-analysis show that, in pain patients,
medium-sized placebo hypoalgesia (Hedges’ g� 0.65) was
induced with a combination of verbal suggestion and
conditioning; however, for this analysis, only three studies
were available, and only experimental pain was investigated
[68].
In a recent study, placebo effects in experimental as
well as chronic pain of patients with musculoskeletal pain
did not differ when induced by verbal suggestion or
a combination of verbal suggestion and conditioning. Yet,
larger placebo responses in chronic pain were found in
responders with more negative treatment history [74],
indicating that prior experience plays an important
moderating role, which, however, could be mediated by
expectations. Investigating patients with atopic dermatitis
with experimental electric pain, placebo hypoalgesia
upon administration of a placebo cream was observed
after verbal suggestion, after conditioning without verbal
suggestion, and after a combination of both. Without
conditioning, however, the effect quickly diminished,
suggesting that conditioning compared to verbal sugges-
tion leads to longer lasting placebo hypoalgesia in patients
[40]. Finally, Klinger et al. [69] tested four different groups
with chronic low back pain in clinical pain, in an exper-
imental electric pain model, in self-rated functional ca-
pacity, and in a behavioral test using time needed to
perform standardized daily activities. Patients received
a sham opioid solution and were either instructed that they
received a placebo (PI) or a pain-reducing opioid solution
(OI). Furthermore, half of the participants underwent
a conditioning procedure, resulting in two more groups
(PI + Cond and OI + Cond). Opioid instruction led to
large placebo effects on clinical and experimental pain, to
decreased time needed for the exercises (small effect), and
to increased self-rated functional capacity (medium ef-
fect). ,e combination with conditioning (OI + Cond)
led to larger effects than OI on all outcome variables.
,e placebo-instructed group with conditioning showed
a small yet significant effect for the time needed to perform
exercises. ,ese results support the notion that condi-
tioning incrementally contributes to placebo hypoalgesia
in patients with low back pain because the effects grew
larger when a combination of conditioning and verbal
suggestion was used, and the behavioral outcome measure
showed placebo effects even in the absence of verbal
suggestions.
,e available studies indicate that both verbal suggestion
and conditioning are powerful determinants of placebo
hypoalgesia in clinical populations. However, not enough
data have been gathered yet to identify the relative signifi-
cance or an independent share of conditioning compared
to explicit expectation in the clinical context. From a theo-
retical perspective, it can be assumed that conditioning
constitutes an important aspect in chronic pain [75]. Es-
pecially, extinction has shown to be deficient in patients with
chronic pain [76]. Furthermore, phenomena like latent
inhibition (i.e., poorer learning as an effect of ineffective
preexposure) or blocking effects (i.e., ineffective responding
to a second conditioned stimulus) increase the risk of
negative treatment experiences. Repeated experience of
therapy failures, which is common in chronic pain, might
lead to weakened placebo or persistent nocebo effects po-
tentially contributing to the maintenance of chronic pain.
However, due to ethical constraints, nocebo hyperalgesia
cannot be investigated as rigorously as placebo hypoalgesia
in clinical samples, and most knowledge in the realm is
derived from studies on the disclosure of possible adverse
effects in clinical trials [77]. On the other hand, there is
limited evidence that conditioned placebo effects are longer
lasting compared to effects that had been induced by explicit
expectation [40, 78], and this could be an opportunity for the
treatment of clinical pain conditions.
6. Conclusion and Future Directions
In sum, conditioning usually leads to the development of
explicit expectation or (more technically) contingency
awareness. Furthermore, it is not surprising that such an
expectation is able to enhance placebo hypoalgesia and
nocebo hyperalgesia as numerous studies have shown when
comparing the effects after verbal suggestion and condi-
tioning with verbal suggestion, respectively [27, 28]. How-
ever, this does not exclude the existence and impact of
conditioned effects that do not depend on explicit expec-
tation. Accordingly, Amanzio and Benedetti [34] elegantly
showed that placebo hypoalgesia that had been conditioned
with ketorolac and enhanced by a verbal suggestion was only
partly reversed by the opioid antagonist naloxone, that is,
naloxone only reversed the placebo effect induced by the
expectation part, as the other experimental groups indicated.
It is conceivable that conditioned effects can be compensated
by or at least interact with contrary explicit expectations
[10, 39]. ,is does not mean, however, that an expectation-
independent, conditioned effect does not exist. We assert
that there is not only one way to elicit placebo and nocebo
effects in pain that is mediation by explicit expectations.
Rather, classical conditioning on its own can generate these
effects, which can be substantial in size, as available evidence
shows for experimental as well as clinical pain.
One possibility to avoid confounding between induction
by expectation and conditioning and to advance our un-
derstanding of the mechanisms causing placebo hypoalgesia
and nocebo hyperalgesia would be the implementation of
implicit conditioning designs. Here, an involvement of
explicit expectations is excluded, and effects purely caused
by conditioning can be investigated. Compared to condi-
tioning with subliminally presented cues, implicit condi-
tioning has some advantages, as discussed above. Another
way would be the development of experimental designs, in
which contrary placebo or nocebo effects are induced by
conditioning and explicit expectation, and these effects are
measured on independent variables.
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